Asset Management Corp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,195
Closed -$202K 192
2020
Q4
$202K Sell
3,195
-6,274
-66% -$379K 0.11% 155
2020
Q3
$598K Sell
9,469
-173
-2% -$12K 0.36% 65
2020
Q2
$742K Buy
9,642
+6,272
+186% +$481K 0.47% 38
2020
Q1
$252K Buy
+3,370
New +$233K 0.23% 95

Other funds holding GILD

Asset Management Corp's GILD Position: Q1 2021 in Review

Asset Management Corp sold out of Gilead Sciences (GILD) in Q1 2021, closing a stake of 3,195 shares — an estimated $202K sold.

Asset Management Corp first reported a position in GILD in Q1 2020 and held it in 4 quarters. The position peaked at $742K in Q2 2020. 1,567 funds tracked by Wall St. Rank hold GILD as of Q1 2021.

  • Asset Management Corp reported no remaining Gilead Sciences position as of Q1 2021 after selling out during the quarter.
  • Asset Management Corp sold 3,195 Gilead Sciences shares in Q1 2021, an estimated $202K.
  • Asset Management Corp first reported a position in Gilead Sciences in Q1 2020 and held it in 4 quarters.
  • Asset Management Corp's Gilead Sciences position peaked at $742K in Q2 2020.
  • 1,567 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2021.

Based on Asset Management Corp's 13F filing for Q1 2021, filed 4 May 2021.